Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of a Novel Valve-Controlled Drug-Elutable Microstent for Microinvasive Glaucoma Surgery: In Vitro and Preclinical In Vivo Studies.
Siewert S, Kischkel S, Brietzke A, Kinzel L, Lindner T, Hinze U, Chichkov B, Schmidt W, Stiehm M, Grabow N, Guthoff RF, Schmitz KP, Stahnke T. Siewert S, et al. Among authors: kinzel l. Transl Vis Sci Technol. 2023 Mar 1;12(3):4. doi: 10.1167/tvst.12.3.4. Transl Vis Sci Technol. 2023. PMID: 36857065 Free PMC article.
Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and Beyond.
Orth M, Albrecht V, Seidl K, Kinzel L, Unger K, Hess J, Kreutzer L, Sun N, Stegen B, Nieto A, Maas J, Winssinger N, Friedl AA, Walch AK, Belka C, Zitzelsberger H, Niyazi M, Lauber K. Orth M, et al. Among authors: kinzel l. Front Oncol. 2021 Mar 17;11:612354. doi: 10.3389/fonc.2021.612354. eCollection 2021. Front Oncol. 2021. PMID: 33816244 Free PMC article.
A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancer.
Kinzel L, Ernst A, Orth M, Albrecht V, Hennel R, Brix N, Frey B, Gaipl US, Zuchtriegel G, Reichel CA, Blutke A, Schilling D, Multhoff G, Li M, Niyazi M, Friedl AA, Winssinger N, Belka C, Lauber K. Kinzel L, et al. Oncotarget. 2016 Jul 12;7(28):43199-43219. doi: 10.18632/oncotarget.9774. Oncotarget. 2016. PMID: 27259245 Free PMC article.
The Women on the Move Through Activity and Nutrition (WOMAN) study: final 48-month results.
Kuller LH, Pettee Gabriel KK, Kinzel LS, Underwood DA, Conroy MB, Chang Y, Mackey RH, Edmundowicz D, Tyrrell KS, Buhari AM, Kriska AM. Kuller LH, et al. Among authors: kinzel ls. Obesity (Silver Spring). 2012 Mar;20(3):636-43. doi: 10.1038/oby.2011.80. Epub 2011 Apr 14. Obesity (Silver Spring). 2012. PMID: 21494228 Free PMC article. Clinical Trial.
The clinical trial of Women On the Move through Activity and Nutrition (WOMAN) study.
Kuller LH, Kriska AM, Kinzel LS, Simkin-Silverman LR, Sutton-Tyrrell K, Johnson BD, Conroy MB. Kuller LH, et al. Among authors: kinzel ls. Contemp Clin Trials. 2007 Jul;28(4):370-81. doi: 10.1016/j.cct.2006.10.009. Epub 2006 Oct 14. Contemp Clin Trials. 2007. PMID: 17113831 Free PMC article. Clinical Trial.
Lifestyle intervention and coronary heart disease risk factor changes over 18 months in postmenopausal women: the Women On the Move through Activity and Nutrition (WOMAN study) clinical trial.
Kuller LH, Kinzel LS, Pettee KK, Kriska AM, Simkin-Silverman LR, Conroy MB, Averbach F, Pappert WS, Johnson BD. Kuller LH, et al. Among authors: kinzel ls. J Womens Health (Larchmt). 2006 Oct;15(8):962-74. doi: 10.1089/jwh.2006.15.962. J Womens Health (Larchmt). 2006. PMID: 17087620 Clinical Trial.
11 results